We found that SRS 16‐86 could improve the recovery of renal function after DN by upregulating glutathione peroxidase 4, glutathione and system xc−light chain and by downregulating the lipid peroxidation markers and 4‐hydroxynonenal. Here, GPX4 is linked to liver dysplastic nodule.